Orchid Pharma receives USFDA approval for Airpiprazole
Orchid Pharma has received final USFDA approval for Aripiprazole Orally-Disintegrating tablets, used in treatment of schizophrenia and bipolar disorder. The drug will be made available […]
Orchid Pharma has received final USFDA approval for Aripiprazole Orally-Disintegrating tablets, used in treatment of schizophrenia and bipolar disorder. The drug will be made available […]
Orchid Pharma has received final USFDA approval for its generic version of rasagiline tablets used in the treatment of Parkinson’s disease. The company expects to […]
Copyright © 2024 | WordPress Theme by MH Themes